Halaman 1 dari 269 hasil
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to an anti-inflammatory or anti-sunburn cosmetic composition.
2. Description of the Prior Art
It is well known that the sunlight and/or lights by artificial light sources, in particular, ultraviolet rays have some
TECHNICAL FIELD OF THE INVENTION
This invention relates to cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods, and food materials.
BACKGROUND OF THE INVENTION
Inflammation by autoimmune diseases
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority under 35 U.S.C. .sctn. 119 to Korean Patent Application No. 10-2017-0050831, filed on Apr. 20, 2017 and Korean Patent Application No. 10-2018-0045029, filed on Apr. 18, 2018, in the Korean Intellectual Property Office, the
This application is a national stage application under 35 U.S.C. .sctn.371 of PCT Application No. PCT/EP2015/054934, filed Mar. 10, 2015, which claims priority of Italy Application No. MI2014A000368, filed Mar. 10, 2014, which are hereby incorporated by reference in their entirety.
FIELD OF THE
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of Korean Patent Application No. 10-2009-102325, filed on Oct. 27, 2009 in the Korean Intellectual Property Office, which is incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
(a) Field of the
This application is a national stage application under 35 U.S.C. .sctn. 371 of PCT Application No. PCT/EP2016/056365, filed 23 Mar. 2016, which claims priority of Italy Application No. 102015000009906, filed 26 Mar. 2015, which are hereby incorporated by reference in their entirety.
FIELD OF THE
FIELD OF THE INVENTION
The present invention relates to mixtures comprising at least one of the fatty acids eicosapentaenoic acid (20:5n3) and docosahexaenoic acid (22:6n3) and the plant Zingiber officinale Roscoe or parts thereof or an extract or a component thereof
More specifically, the invention
Novel pharmaceuticals. dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain.
FIELD OF THE INVENTION
The present invention relates to
The present invention relates to inflammation inhibitors for use in cosmetic preparations, particularly for use in agents for protection against, and the treatment of, sunburn, based on alkoxybenzoic acid esters.
OBJECTS OF THE INVENTION
An object of the present invention is the development of a
BACKGROUND ART
An anti-inflammatory agent is a substance that suppresses inflammatory cytokines and/or inflammatory mediators (such as prostaglandins). Aspirin and teprenone are known examples of anti-inflammatory agents.
A cancer-preventive agent is a substance that prevents carcinogenesis induced
PRIORITY CLAIM
This is a U.S. national stage of application No. PCT/JP2014/055647, filed on Mar. 5, 2014. Priority is claimed on the following applications: Country: Japan, Application No.: 2013-181052, Filed: Sep. 2, 2013), the content of which is incorporated here by reference
TECHNICAL FIELD
The
FIELD OF THE INVENTION
This invention relates to synthetic compounds that present significant effectiveness in the treatment and/or care of the skin and/or mucous membranes, and in particular they useful in the treatment and/or care of those conditions, disorders and/or diseases that improve or are
BACKGROUND OF THE INVENTION
Halofuginone is a halogenated derivative of febrifugine, a natural product extracted from the roots of the hydrangea Dichroa febrifuga. Dichroa febrifuga is one of the "fifty fundamental herbs" of traditional Chinese medicine, originally used as an anti-malarial remedy
FIELD OF THE INVENTION
The present invention substantially relates to the technical field of drugs, cosmetics, medical products, disinfecting products, healthcare products, food, and household chemicals, and more specifically, relates to a mussel adhesive protein product and a use thereof for
The subject of the present invention is, in the most general aspect, an extract of at least one plant of the Labiatae family, the said plant being cultured in vitro.
It also relates to a cosmetic or pharmaceutical composition comprising, as active ingredient, at least an effective quantity of such